Navigation Links
Preliminary Research Results Suggest up to 70% Reduction in Dose for Positron Emission Mammography Imaging
Date:8/23/2010

esults are the basis of an ongoing clinical trial at Swedish Cancer Institute with the goal of determining the optimized dose levels of FDG required to produce high quality PEM images in patients with breast cancer.

"Naviscan believes that the radiation dose to patients who undergo PEM can be cut at least in half, if not more as suggested by the University of Washington study," said Judy Kalinyak, MD, Medical Director, Naviscan, Inc.  "Our site in Japan is already injecting 5 mCi of FDG compared to the 10 mCi in the US and a recently published abstract in The Journal of Nuclear Medicine further validates the reduction in dose down to 5 mCi."

Results from a recent presentation at the Society of Nuclear Medicine on findings from an NIH-sponsored clinical study comparing PEM with breast MRI further demonstrate PEM's clinical appropriateness. This multi-site study (NIH Grant 5R44CA103102) of hundreds of women with newly diagnosed breast cancer shows that PEM demonstrated a six percent improvement in specificity at comparably high sensitivity, and also recommended fewer unnecessary biopsies. These results are particularly significant for women who cannot tolerate an MRI exam and require an alternate imaging tool. The study is slated for publication in the December issue of the journal Radiology.

About Naviscan, Inc.

Naviscan, founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging and guide radiological and surgical procedures. The Naviscan PEM scanner is currently installed and available in breast and imaging centers throughout the U.S. and other parts of the world. The Company is headquartered in San Diego, California and is the first to obtain FDA-clearance for a high-resolution PET scanner designed to image small body parts and for breast biopsy image guidance. For more information, call 1.858.587.3641 or visit www
'/>"/>

SOURCE Naviscan
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Quest Diagnostics Care360™ EHR Module Receives Preliminary ARRA IFR Stage 1 Certification
2. Lilly Halts Development of Semagacestat for Alzheimers Disease Based on Preliminary Results of Phase III Clinical Trials
3. Renhuang Announces Successful Preliminary Review of Its Patent Application for Schisandra Total Lignin Extraction Method
4. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
5. ISTA Pharmaceuticals Announces Preliminary, Unaudited Revenue of $110.6 Million in 2009
6. Osteotech Announces Preliminary Fourth Quarter 2009 Revenue
7. ATS Medical Announces Preliminary Fourth Quarter 2009 Results
8. Volcano Corporation Announces Preliminary Record Revenues for Fourth Quarter 2009; Total Year Revenues are Expected to Exceed Prior Guidance
9. Maxygen, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
10. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
11. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
(Date:8/27/2015)... 27, 2015  The Academy of Managed Care ... Administration,s (FDA,s) draft guidance and proposed rule that ... to bear a nonproprietary name with an FDA-designated ... a decision from the FDA on the naming ... stakeholders urging the agency to use the same ...
(Date:8/27/2015)... , Aug. 27, 2015 Biosimilars ... (BPC) applauds the U.S. Food and Drug Administration ... distinguishable name in its draft guidance issued today. ... biological products proposes distinguishable names, calling for biological ... an FDA-designated suffix. This proposal reflects the agency,s ...
Breaking Medicine Technology:Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2
... CHARENTON-LE-PONT, France , July 13, 2010 ... its,commitment not to create any dilution for existing shareholders. The two-part,transaction was ... were cancelled to offset the dilutive impact of the, ... granted, to employees., - ...
... NEW YORK , July 12 DrChrono.com , the premier ... world-renowned iPad EMR app , featuring the ability to build macros and customizable ... DrChrono.com and its iPad EMR ... Wall Street Journal , Newsday , The Health ...
Cached Medicine Technology:Essilor Cancels Four Million Shares 2DrChrono.com iPad EMR Introduces Macros, Customizable SOAP Notes 2DrChrono.com iPad EMR Introduces Macros, Customizable SOAP Notes 3DrChrono.com iPad EMR Introduces Macros, Customizable SOAP Notes 4
(Date:8/28/2015)... ... ... Rio Salado College joined nine educational institutions in Washington D.C., July ... - Next Generation Learning Challenges 2015 Breakthrough Models Incubator funded by the Bill ... hosted by EDUCAUSE and NGLC, which is designed to bring leadership teams of ...
(Date:8/28/2015)... ... August 28, 2015 , ... Approximately 2,000 United Methodists ... celebrate children helping children, a thank you to the many creative and generous ... to the United Methodist initiative to end malaria deaths. , The Columbus Zoo ...
(Date:8/28/2015)... ... , ... With the goal of furthering music education programs in schools, the ... County Fairgrounds in Mendon, IL on May 30th, 2015. Backed once again by Best ... the underfunded school districts of Mendon and its neighboring town of Quincy, IL. Best ...
(Date:8/28/2015)... , ... August 28, 2015 , ... As reported ... Merz, received FDA clearance for results that last for two years, the longest ... news for patients who are looking for a long-lasting, effective solution for their cellulite, ...
(Date:8/28/2015)... Michigan (PRWEB) , ... August 28, 2015 , ... ... alcohol abuse, or those who might personally be struggling with chemical dependency, may ... post from Best Drug Rehabilitation, a results-driven holistic treatment center for addiction located ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3
... Harbor Laboratory (CSHL) has demonstrated for the first time ... can initiate signaling that regulates both the structure and ... suggests a significant role for this class of receptors ... but also in cognition and in pathological processes in ...
... strike small percentage of patients , , WEDNESDAY, June 18 ... new side effect associated with the cancer drug Gleevec ... leukemia and gastrointestinal stromal tumors. , In a letter ... New England Journal of Medicine , the doctors describe ...
... Controlling heart rate is key when heart failure, irregular ... News) -- When added to heart failure, the irregular ... , Now, an international study shows that a ... best first option for keeping patients healthy under these ...
... HILL, N.C., June 18 A CI head once ... have it, but the only,time you realize you need ... In today,s marketing space, most companies need competitive,intelligence to ... the key insights are lacking that people begin to ...
... Prevent Skin Cancer, HOUSTON, June 18 Now that ... us, the cancer care experts at Texas Oncology remind,Texans to ... Although the most prevalent cancer in the United States today,skin ... more than 1,million annual U.S. cases of skin cancer are ...
... List from a ... Worldwide Field of 5,000, PHILADELPHIA, June ... of SCA Personal Care, from among,5,000 companies for inclusion in its ... think-tank dedicated to the research and,promotion of profitable best practices in ...
Cached Medicine News:Health News:Neuroscientists show insulin receptor signaling regulates structure of brain circuits 2Health News:Neuroscientists show insulin receptor signaling regulates structure of brain circuits 3Health News:Cancer Drug Gleevec Linked to Muscle Damage 2Health News:Cardiologists Spot Best Treatment for a Deadly Duo 2Health News:Cardiologists Spot Best Treatment for a Deadly Duo 3Health News:Build and Maintain an Effective Competitive Intelligence Group 2Health News:Texas Oncology Urges Texans to 'Save Your Skin' 2Health News:Texas Oncology Urges Texans to 'Save Your Skin' 3Health News:Ethisphere Institute Names SCA to List of Top Ethical Companies 2
... new Finnpipette Focus from Thermo ... combine ergonomics with uncompromising performance. ... plate offers a custom fit ... new shorter tip cones allow ...
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
... is ideal for repeated pipetting ... volume FInnpipettes offer the same ... Finnpipette Digital pipettes: New, ... Soft-touch tip ejection, Safety label, ...
... Focus from Thermo Labsystems was ... with uncompromising performance. The ... a custom fit for different ... tip cones allow easier and ...
Medicine Products: